Keryx Biopharmaceuticals to Present at the J.P. Morgan 28th Annual Healthcare ... - PR Newswire (press release) PDF Print
PR Newswire (press release)The Phase 3 clinical program of Zerenex in the treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.